1. This symposium is funded
through an educational grant
from Bracco Diagnostics.
A breakfast symposium conducted at the
49th ASHP Midyear Clinical Meeting and Exhibition
Institute for Safe Medication Practices (ISMP)
200 Lakeside Drive, Suite 200, Horsham, PA 19044
Phone: (215) 947-7797 www.ismp.org
For registration questions, contact ProCE at 1-800-748-7795.
Overview
Radiology departments often use medications in ways that are
different from other clinical areas of the hospital, and staff may
not be aware of the significant safety issues that can arise. This
symposium will explore current medication safety issues in the
radiology setting, such the safe use of contrast, appropriate
labeling of containers, beyond-use dating, and patient
identification. Nationally known experts will discuss actual
cases where errors have occurred and risk reduction strategies,
including use of technology and best practices. A new Imaging
Bulk Package for contrast recently approved by the US Food and
Drug Administration (FDA) as well as regulatory and The Joint
Commission accreditation requirements for use of contrast and
other medications in radiology will also be discussed.
Objectives
The target audience for this activity includes pharmacists in
health-system settings. At the completion of this symposium,
the participant should be able to:
• Describe how medications and contrast agents are ordered,
stored, prepared, and utilized in the radiology setting.
• Explain the difference between the new FDA classification
of an imaging bulk package vs. a pharmacy bulk package of
contrast, and why FDA developed this new product type.
• Identify system-based causes of medication errors
associated with the use of medications and contrast agents
in radiology.
• Prioritize selected strategies to prevent harm and improve
medication safety in radiology.
• Describe current regulatory and accreditation requirements
related to the use of medications and contrast agents
in radiology, and the role of the pharmacy in assuring
compliance with the standards.
Improving Medication Safety
in the Radiology Setting
Breakfast Symposium
Monday, December 8, 2014
Pacific Ballroom D
Hilton Anaheim
Breakfast 6:15 AM – 6:45 AM
Symposium 6:45 AM – 8:45 AM
Space is limited and pre-registration is encouraged. Pre-registration is for planning
purposes only and seating will be available on a first-come, first-served basis.
To register, please go to: www.ProCE.com/ISMP2014
Topics and Faculty
Introduction and Program Overview
Janice Dunsavage, RPh, MAS, Chair, ISMP Board of Trustees and
Director of Pharmacy, PinnacleHealth, Harrisburg, PA
Primer on Medication Administration Systems and Medications
Used in Radiology
Lior Molvin, (MBA) (RT) (R) (CT), CT Protocol Technologist, CT Protocol
Development and Education Team, Stanford University Medical Center and
Stanford Medicine, Imaging Center, Palo Alto, CA
Medication Safety Issues and Recommended Strategies
Matthew P. Fricker, Jr, MS, RPh, FASHP, Program Director, ISMP
Centers for Medicare & Medicaid Services (CMS) and
The Joint Commission Requirements
Darryl S. Rich, PharmD, MBA, FASHP, Medication Safety Specialist, ISMP
Question and Answer Session
Janice Dunsavage, RPh, MAS, Chair, ISMP Board of Trustees and
Director of Pharmacy, PinnacleHealth, Harrisburg, PA
Accreditation
This CE activity is jointly provided by ProCE, Inc. and the Institute
for Safe Medication Practices (ISMP). ProCE is accredited by the
Accreditation Council for Pharmacy Education as a provider of
continuing pharmacy education. ACPE Universal Activity Number
0221-9999-14-227-L05-P has been assigned to this knowledge-based
live CE activity (initial release date December 8, 2014). This CE activity
is approved for 2.0 contact hours (0.20 CEUs) in states that recognize
ACPE providers. This CE activity is provided at no cost to participants. Successful
completion of the online post-test and evaluation at www.ProCE.com no later than
January 9, 2015 is required to receive CE credit. CE credit will be automatically
uploaded to NABP/CPE Monitor within 1 to 2 weeks of the completion of the post-
test and evaluation. No partial credit will be given. Conflict of interest disclosures
are required of all faculty and shall be provided to all participants at the conference.